April 14 (Reuters) - Inhibikase Therapeutics Inc IKT.O:
INHIBIKASE THERAPEUTICS ANNOUNCES APPOINTMENT OF DAVID MCINTYRE AS CHIEF FINANCIAL OFFICER
INHIBIKASE THERAPEUTICS INC - APPOINTMENT OF DAVID MCINTYRE AS CHIEF FINANCIAL OFFICER, EFFECTIVE APRIL 14, 2025
Source text: ID:nGNX5q06tF
Further company coverage: IKT.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.